Through the lens of rural patients and pharmacies: A content analysis of state level pharmacy benefit manager regulations and policies

IF 1.8 Q3 PHARMACOLOGY & PHARMACY
Tyler C. Melton , MaryKathleen Ryan , Andrew M. Stallings , Sang H. Park , Cameron Lanier , Jordan Marie Ballou , Meagen Rosenthal
{"title":"Through the lens of rural patients and pharmacies: A content analysis of state level pharmacy benefit manager regulations and policies","authors":"Tyler C. Melton ,&nbsp;MaryKathleen Ryan ,&nbsp;Andrew M. Stallings ,&nbsp;Sang H. Park ,&nbsp;Cameron Lanier ,&nbsp;Jordan Marie Ballou ,&nbsp;Meagen Rosenthal","doi":"10.1016/j.rcsop.2025.100595","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pharmacy Benefit Managers (PBMs) are responsible for establishing community pharmacy reimbursement practices and prices to varying degrees. Understanding PBMs' reimbursement practices is necessary for the continued viability of community pharmacies located in underserved and rural patient communities. Currently, there is a gap in literature exploring PBM reform and the impact this legislation has on rural pharmacy practice.</div></div><div><h3>Objectives</h3><div>This content analysis reviews the legislation complied by the National Community Pharmacists Association (NCPA) and determines its benefits to pharmacies and patients in rural areas.</div></div><div><h3>Methods</h3><div>The NCPA PBM Reform legislation document included bills from 48 states and the District of Columbia, that were introduced between November 30, 2018, through December 7, 2021. Bills were classified as enacted (<em>n</em> = 81), in debate (<em>n</em> = 186), or as having failed to be enacted (<em>n</em> = 120). Eighty-one enacted bills were reviewed to assess if it benefited patients, pharmacies, or both. Bills not benefiting either pharmacies or patients were excluded.</div></div><div><h3>Results</h3><div>Fifty-seven bills were included in the content analysis, where six categories were identified using thematic analysis and classified as: PBM Operations, Drug Pricing, Transparency, Reimbursements, Cost Sharing, and Prior Authorization. Only twenty-two bills were identified as potentially benefitting both rural pharmacies and rural patients through inclusion of legislation managing PBM practices involving patient steering, network adequacy, pricing transparency, reforming cost-sharing structures, and streamlining prior authorization processes.</div></div><div><h3>Conclusions</h3><div>This study identifies multiple PBM legislation categories having the potential to impact rural pharmacy operations and patient outcomes. However, further research is needed to understand the specific financial and clinical impact of these PBM legislation categories on rural communities and rural pharmacy practice, as well as their alignment with enabling pharmacists to combat unique health disparities and challenges facing rural communities.</div></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":"18 ","pages":"Article 100595"},"PeriodicalIF":1.8000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667276625000368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Pharmacy Benefit Managers (PBMs) are responsible for establishing community pharmacy reimbursement practices and prices to varying degrees. Understanding PBMs' reimbursement practices is necessary for the continued viability of community pharmacies located in underserved and rural patient communities. Currently, there is a gap in literature exploring PBM reform and the impact this legislation has on rural pharmacy practice.

Objectives

This content analysis reviews the legislation complied by the National Community Pharmacists Association (NCPA) and determines its benefits to pharmacies and patients in rural areas.

Methods

The NCPA PBM Reform legislation document included bills from 48 states and the District of Columbia, that were introduced between November 30, 2018, through December 7, 2021. Bills were classified as enacted (n = 81), in debate (n = 186), or as having failed to be enacted (n = 120). Eighty-one enacted bills were reviewed to assess if it benefited patients, pharmacies, or both. Bills not benefiting either pharmacies or patients were excluded.

Results

Fifty-seven bills were included in the content analysis, where six categories were identified using thematic analysis and classified as: PBM Operations, Drug Pricing, Transparency, Reimbursements, Cost Sharing, and Prior Authorization. Only twenty-two bills were identified as potentially benefitting both rural pharmacies and rural patients through inclusion of legislation managing PBM practices involving patient steering, network adequacy, pricing transparency, reforming cost-sharing structures, and streamlining prior authorization processes.

Conclusions

This study identifies multiple PBM legislation categories having the potential to impact rural pharmacy operations and patient outcomes. However, further research is needed to understand the specific financial and clinical impact of these PBM legislation categories on rural communities and rural pharmacy practice, as well as their alignment with enabling pharmacists to combat unique health disparities and challenges facing rural communities.
以农村患者和药店为视角:国家级药房福利管理法规政策的内容分析
药房福利管理者(PBMs)在不同程度上负责建立社区药房报销实践和价格。了解药品福利管理公司的报销做法对于服务不足和农村患者社区的社区药房的持续生存是必要的。目前,探讨药品福利管理改革及其立法对农村药学实践的影响的文献还存在空白。目的对全国社区药师协会(NCPA)所遵守的立法进行内容分析,确定其对农村地区药房和患者的益处。NCPA PBM改革立法文件包括来自48个州和哥伦比亚特区的法案,这些法案是在2018年11月30日至2021年12月7日期间提出的。法案分为已通过(81件)、正在讨论(186件)和未通过(120件)三类。81项已通过的法案进行了审查,以评估它是否对患者、药店或两者都有利。对药店和病人都没有好处的法案被排除在外。结果57份法案被纳入内容分析,通过专题分析确定了6个类别,分别为:药品福利管理操作、药品定价、透明度、报销、成本分担和事先授权。只有22项法案被确定为可能使农村药房和农村患者受益,这些法案包括管理药品福利管理实践的立法,包括患者指导、网络充分性、定价透明度、改革成本分担结构和简化事先授权程序。本研究确定了多种药品福利管理立法类别,这些立法类别有可能影响农村药房的运营和患者的治疗结果。然而,需要进一步的研究来了解这些PBM立法类别对农村社区和农村药房实践的具体财务和临床影响,以及它们与使药剂师能够应对农村社区面临的独特健康差异和挑战的一致性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信